Har Grover

, ,
Chairman, Scientus Pharma

Har Grover is an entrepreneur, investor, senior executive and strategist with over 30 years of experience in healthcare, life sciences and technology. He has worked with growth companies at all stages, from start-up to commercialization, to going public and growing through the $1 billion revenue mark. Har has helped companies enter new markets both in Canada and internationally – organically and through M&A, strategic alliances, and joint ventures. He is the Co-Founder of Scientus Pharma, CannScience Innovations and Nucleus GC.

Har has served on several corporate and non-profit boards including: Chair of Armour Therapeutics, Chair of Crohn’s and Colitis Canada, Board Director of Medworxx, Board Director of MedcannAccess. Har has an undergraduate degree in life sciences, and a MBA. He obtained professional CMC and ICD.D designations.